𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preferences for Human Papillomavirus Testing with Routine Cervical Cancer Screening in Diverse Older Women

✍ Scribed by Alison J. Huang; Eliseo J. Pérez-Stable; Sue E. Kim; Sabrina T. Wong; Celia P. Kaplan; Judith M. E. Walsh; A. Yuri Iwaoka-Scott; George F. Sawaya

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
143 KB
Volume
23
Category
Article
ISSN
0884-8734

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Guidelines for human papillomavirus DNA
Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
✍ Chris J.L.M. Meijer; Johannes Berkhof; Philip E. Castle; Albertus T. Hesselink; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 120 KB 👁 1 views

## Abstract Given the strong etiologic link between high‐risk HPV infection and cervical cancer high‐risk HPV testing is now being considered as an alternative for cytology‐based cervical cancer screening. Many test systems have been developed that can detect the broad spectrum of hrHPV types in on

Test positivity cutoff level of a high r
Test positivity cutoff level of a high risk human papillomavirus test could be increased in routine cervical cancer screening
✍ Laura Kotaniemi-Talonen; Nea Malila; Pekka Nieminen; Ahti Anttila; Jussi Tarkkan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB 👁 2 views

## Abstract We present data on test positivity, relative sensitivity, rates of detection and relative specificity for primary human papillomavirus (HPV) testing with different cutoff levels for test positivity, in comparison to conventional cytology. In 2003–2004, 18,438 women were screened primari

Evaluation of cervical screening strateg
Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis
✍ Johannes Berkhof; Martine C. de Bruijne; Gilda D. Zielinski; Nicole W.J. Bulkman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 351 KB

## Abstract The management of women with a smear read as borderline/mild dyskaryosis (BMD) found by cervical cancer screening is still under discussion as only few of these cases are associated with high‐grade lesions. To determine the optimal screening strategy for these women, a simulation model

Human papillomavirus testing and cervica
Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: Comparison of sensitivity, specificity, and frequency of referral
✍ Lisa M. Moy; Fang-Hui Zhao; Long-Yu Li; Jun-Fei Ma; Qing-Ming Zhang; Feng Chen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 431 KB 👁 2 views

## Abstract The causal relationship between persistent high‐risk human papillomavirus infection and cervical cancer is widely accepted. HR‐HPV DNA testing, alone or in combination with Pap smear testing, may have a role in primary screening. The screening results (VIA, VILI, Pap, and HR‐HPV DNA) of

Evaluation of oncogenic human papillomav
Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: The FASE study
✍ Joseph Monsonego; Michael G. Hudgens; Laurent Zerat; Jean-Claude Zerat; Kari Syr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto